Cargando…
MON-675 Ziprasidone Induced Diabetic Ketoacidosis
Introduction: Atypical antipsychotics are known to cause increased risk of type 2 Diabetes Mellitus (DM2), dyslipidemia, and weight gain (metabolic syndrome). Clozapine, a commonly used anti-psychotic, is known to cause Diabetic Ketoacidosis (DKA), but literature has rarely shown an association of D...
Autores principales: | Thanikonda, Varshitha, Jalil, Fatima, Kantorovich, Vitaly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209382/ http://dx.doi.org/10.1210/jendso/bvaa046.463 |
Ejemplares similares
-
MON-128 Pneumomediastinum in Diabetic Ketoacidosis
por: Poudel, Resham, et al.
Publicado: (2019) -
SAT-675 Relapsing Diabetic Ketoacidosis During Stepdown from Intensive Care Unit
por: Zakai, Yusha, et al.
Publicado: (2020) -
MON-127 Euglycemic Diabetic Ketoacidosis: A Rare Complication of a Common Disease
por: Kazi, Fatima, et al.
Publicado: (2019) -
MON-143 Diabetic Ketoacidosis Confounding Diagnosis of Acromegaly with Microadenoma
por: Yakubov, Mikhail, et al.
Publicado: (2019) -
MON-614 Degree of Diabetes Control Determines the Admission Severity of Diabetic Ketoacidosis
por: Grover, Harshwant, et al.
Publicado: (2020)